Page 30 - Care Testing News Today : Breaking News, Live Updates & Top Stories | Vimarsana

COVID-19 Point of Care Testing: The LumiraDx Platform, Upcoming Webinar Hosted by Xtalks Share Article In this free webinar, the featured speaker will discuss how the LumiraDx point of care diagnostic platform is able to uniquely combine sensitivity with speed, presenting actionable test results in minutes. The clinical performance of the LumiraDx SARS-CoV-2 Antigen Test and correlation with patient infectivity will be outlined. The SARS-CoV-2 Antibody Test (CE marked) which allows practitioners to test for antigen and antibody results on a single platform will also be introduced. We will als...

Share this article Share this article ResearchAndMarkets.com's offering. The market has just gotten started with a handful of small startup companies. Expect the big players to start taking notice. CRISPR is not just about changing genes. CRISPR identifies unique genetic material instantly, accurately and cheaply. A whole new world of identification and diagnostics opens up. Find out exactly what kind of cold or flu you have. Find out exactly what kind of fish you are eating. Instantly detect the presence of unwelcome bacteria, anywhere. A new COVID test is already available. Will this disrup...

Point Of Care Testing Market Repository of Analysis and Information for Every Facet of the Market Point of care (POC) technologies are rapidly becoming part of the revolution of the healthcare landscape. BriefingWire.com, 4/16/2021 - Point of care (POC) technologies are rapidly becoming part of the revolution of the healthcare landscape. With evolving high–tech innovations in healthcare, including smartphone apps, biosensors, lab–on–a chip, and wearable devices—all of which offer a closer connection to the patient. The dynam...

Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following

Share this article Share this article ResearchAndMarkets.com's offering. The scope of this report is broad and covers the components available in the polymerase chain reaction (PCR) for point-of-care (POC) diagnostics market and potential end-users. Revenue forecasts from 2020 to 2025 are given for types of kits and equipment, with estimated value derived from the revenues of manufacturers. The report also includes a discussion on the major players in each regional market. Further, it explains major drivers and regional dynamics of the global market. The report concludes with a look at the ve...